Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TBC1 domain family member 8B (TBC1D8B) is a protein coding gene that encodes a Rab-GTPase-activating protein, featuring a TBC (Tre-2/Bub2/CDC16) domain and GRAM domains which bind to lipid rafts[1][2][3][6][7]. TBC1D8B is primarily involved in the regulation of endocytosis and vesicular recycling, especially in podocytes of the kidney, where it interacts with Rab11b, regulating the internalization and recycling of proteins critical for glomerular filtration barrier integrity[2][3][4][6]. Mutations in TBC1D8B are associated with X-linked steroid-resistant nephrotic syndrome and hereditary kidney diseases, likely due to altered vesicle trafficking, impaired migration, and defective signaling in podocyte cells[2][6]. While not a classical receptor, enzyme, or transporter, TBC1D8B is considered a disease gene/protein; it has not been directly targeted by drugs, nor are there known drugs modulating its action or validated biomarkers for clinical use[1][3][6][13].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TBC1 domain family member 8B (TBC1D8B).